The Kaplan‐Meier database revealed that high RACK1 expression in liver cancer patients was negatively associated with the overall survival, recurrence‐free survival and progression‐free survival (Figure 2I), demonstrating that RACK1 is a therapeutic target for liver cancer. This evidence concerns the gene RACK1 and liver cancer.